Viscoli C - Search Results

1

Use of raltegravir in a late presenter HIV-1 woman in advanced gestational age: case report and literature review.

De Hoffer L, Di Biagio A, Bruzzone B, Sticchi L, Prinapori R, Gerbaldo D, Gotta C, Viscoli C. De Hoffer L, et al. Among authors: viscoli c. J Chemother. 2013 Jun;25(3):181-3. doi: 10.1179/1973947812Y.0000000066. J Chemother. 2013. PMID: 23783144

2

Simplification to monotherapy with lopinavir/ritonavir in adolescents with vertically acquired HIV-1 infection.

Schenone E, Di Biagio A, Parisini A, Bruzzone B, Sticchi L, Calzi A, Nicco E, Secondo G, Viscoli C. Schenone E, et al. Among authors: viscoli c. J Chemother. 2012 Feb;24(1):56-8. doi: 10.1179/1120009X12Z.00000000011. J Chemother. 2012. PMID: 22546725

3

Potential role of raltegravir-based therapy to induce rapid viral decay in highly viraemic HIV-infected neonates.

Ripamonti D, Tatarelli P, Mangili G, Gotta C, Benatti SV, Bruzzone B, Callegaro A, Viscoli C, Ruggeri M, Di Biagio A. Ripamonti D, et al. Among authors: viscoli c. J Chemother. 2016 Aug;28(4):337-40. doi: 10.1179/1973947814Y.0000000217. J Chemother. 2016. PMID: 25248795

4

Safety and efficacy of pegylated interferon and ribavirin in adolescents with human immunodeficiency virus and hepatitis C virus acquired perinatally.

Rosso R, Di Biagio A, Mikulska M, Nicco E, Bernardini C, Viscoli C. Rosso R, et al. Among authors: viscoli c. J Med Virol. 2010 Jul;82(7):1110-4. doi: 10.1002/jmv.21802. J Med Virol. 2010. PMID: 20513072

5

HIV and accelerated atheroprogression: role of antiretroviral therapy.

Di Biagio A, Del Bono V, Rosso R, Viscoli C. Di Biagio A, et al. Among authors: viscoli c. Curr Pharm Biotechnol. 2012 Jan;13(1):88-96. doi: 10.2174/138920112798868520. Curr Pharm Biotechnol. 2012. PMID: 21470158

6

Patient-reported outcomes and low-level residual HIV-RNA in adolescents perinatally infected with HIV-1 after switching to one-pill fixed-dose regimen.

Rosso R, Di Biagio A, Maggiolo F, Nulvesu L, Callegaro AP, Taramasso L, Bruzzone B, Viscoli C. Rosso R, et al. Among authors: viscoli c. AIDS Care. 2012;24(1):54-8. doi: 10.1080/09540121.2011.596511. Epub 2011 Jul 29. AIDS Care. 2012. PMID: 21800951

7

Lamivudine resistance mutations in European patients with hepatitis B and patients co-infected with HIV and hepatitis B.

Taramasso L, Caligiuri P, Di Biagio A, Bruzzone B, Rosso R, Icardi G, Viscoli C. Taramasso L, et al. Among authors: viscoli c. J Med Virol. 2011 Nov;83(11):1905-8. doi: 10.1002/jmv.22192. J Med Virol. 2011. PMID: 21915864

8

Effects of hepatitis C virus infection on the pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected patients.

Di Biagio A, Rosso R, Loregian A, Pagni S, Sormani MP, Cenderello G, Palù G, Viscoli C. Di Biagio A, et al. Among authors: viscoli c. J Infect Chemother. 2012 Aug;18(4):587-90. doi: 10.1007/s10156-012-0402-y. Epub 2012 Mar 16. J Infect Chemother. 2012. PMID: 22422300

9

Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir.

Mikulska M, Taramasso L, Giacobbe DR, Caligiuri P, Bruzzone B, Di Biagio A, Viscoli C. Mikulska M, et al. Among authors: viscoli c. J Med Virol. 2012 Sep;84(9):1340-3. doi: 10.1002/jmv.23338. J Med Virol. 2012. PMID: 22825811

10

Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo.

Bisio F, Masini G, Blasi Vacca E, Calzi A, Cardinale F, Bruzzone B, Bruzzi P, Viscoli C; Kento-Mwana group. Bisio F, et al. Among authors: viscoli c. J Antimicrob Chemother. 2013 Aug;68(8):1862-71. doi: 10.1093/jac/dkt102. Epub 2013 Apr 14. J Antimicrob Chemother. 2013. PMID: 23587655 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

567 results

Search Page

Filters